Gainers
-
Baytex Energy Corp (USA) (NYSE: BTE) rose 10.2
percent to $3.02 in pre-market trading after reporting 2017 results.
-
Ameresco Inc (NYSE: AMRC) shares rose 10.2 percent
to $9.20 in pre-market trading following upbeat Q4 results.
-
Analogic Corporation (NASDAQ: ALOG) shares rose
10.1 percent to $93.50 in the pre-market trading session following strong Q2 results.
-
Frontline Ltd. (NYSE: FRO) rose 9.9 percent to $4.44
in pre-market trading.
-
Tarena International Inc(ADR) (NASDAQ: TEDU) rose
8.4 percent to $13.50 in pre-market trading after the company reported Q4 results and declared a special dividend of $0.12 per
share.
-
Baozun Inc (ADR) (NASDAQ: BZUN) rose 8.2 percent
to $39.76 in pre-market trading after reporting Q4 results.
-
Ciena Corporation (NYSE: CIEN) rose 6.3 percent to
$24.82 in pre-market trading after the company reported better-than-expected results for its first quarter.
-
Vale SA (ADR) (NYSE: VALE) shares rose 6.3 percent
to $14.26 in pre-market trading.
-
Casa Systems Inc (NASDAQ: CASA) shares rose 6.3
percent to $24.98 in pre-market trading after gaining 7.06 percent on Monday.
-
Trevena Inc (NASDAQ: TRVN) shares rose 6.2
percent to $2.05 in pre-market trading after gaining 4.32 percent on Monday.
-
Celldex Therapeutics, Inc. (NASDAQ: CLDX) rose
6.2 percent to $2.56 in pre-market trading after gaining 3.43 percent on Monday.
-
Infinera Corp. (NASDAQ: INFN) shares rose 6.1
percent to $11.11 in pre-market trading.
-
Euronav NV (NYSE: EURN) rose 5.4 percent to $8.85
in pre-market trading.
-
TG Therapeutics Inc (NASDAQ: TGTX) rose 5.3
percent to $16 in pre-market trading after gaining 1.50 percent on Monday.
-
Enphase Energy Inc (NASDAQ: ENPH) rose 5.2
percent to $3.90 in pre-market trading after gaining 8.16 percent on Monday
- NetApp Inc. (NASDAQ: NTAP) rose 4.8 percent to
$65.18 in pre-market trading after gaining 2.35 percent on Monday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and
losers
Losers
-
GlycoMimetics Inc (NASDAQ: GLYC) fell 16.8
percent to $18.99 in pre-market trading after reporting the design of phase 3 trial of GMI-1271 in relapsed/refractory AML.
GlycoMimetics reported a Q4 loss of $0.27 per share.
-
TransAct Technologies Incorporated (NASDAQ: TACT)
shares fell 12.8 percent to $11.95 in pre-market trading following a fourth quarter earnings and sales miss. The company also
announced a $5 million share buyback plan.
-
Ascena Retail Group Inc (NASDAQ: ASNA) shares
fell 12 percent to $2.13 in pre-market trading after the company posted a wider-than-expected loss for its second quarter and
issued weak third-quarter earnings guidance.
-
Innovate Biopharmaceuticals Inc (NASDAQ: INNT)
shares fell 7.5 percent to $16.00 in pre-market trading after rising 82.49 percent on Monday.
-
Insys Therapeutics Inc (NASDAQ: INSY) shares fell
6.7 percent to $7.52 in pre-market trading after gaining 3.73 percent on Monday.
-
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) fell
6.3 percent to $2.55 in the pre-market trading session after rising 31.40 percent on Monday.
-
Target Corporation (NYSE: TGT) shares fell 4.5
percent to $71.81 in pre-market trading after the company reported downbeat earnings for its fourth quarter.
-
Vericel Corp (NASDAQ: VCEL) fell 4.2 percent to
$11.35 in pre-market trading after climbing 41.92 percent on Monday.
-
51job, Inc. (ADR) (NASDAQ: JOBS) shares fell 3.1
percent to $73.87 in pre-market trading after declining 0.20 percent on Monday.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.